Opexa CEO presentation
Posted: Mon Oct 30, 2006 10:33 pm
Opexa Therapeutics to Present at C.E. Unterberg, Towbin Life Sciences Investor Conference
THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, today announced that David McWilliams, Opexa’s chief executive officer, will present at the C.E. Unterberg, Towbin Life Sciences Conference on Tuesday, October 31, 2006, at 2:00 PM Eastern Time. The conference will be held at the Palace Hotel in New York City from October 30 through October 31, 2006.
Individuals may listen to a live web cast of the presentation by logging on to the Investor Relations section of Opexa’s web site www.opexatherapeutics.com a few minutes prior to start time to download any necessary software. The C.E. Unterberg, Towbin Life Sciences Conference will feature representatives from 95 emerging growth companies from biotechnology, medical technology, drug delivery and specialty pharmaceuticals sectors.
THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company involved in the development and commercialization of cell therapies, today announced that David McWilliams, Opexa’s chief executive officer, will present at the C.E. Unterberg, Towbin Life Sciences Conference on Tuesday, October 31, 2006, at 2:00 PM Eastern Time. The conference will be held at the Palace Hotel in New York City from October 30 through October 31, 2006.
Individuals may listen to a live web cast of the presentation by logging on to the Investor Relations section of Opexa’s web site www.opexatherapeutics.com a few minutes prior to start time to download any necessary software. The C.E. Unterberg, Towbin Life Sciences Conference will feature representatives from 95 emerging growth companies from biotechnology, medical technology, drug delivery and specialty pharmaceuticals sectors.